REVIEW ARTICLE |
|
Year : 2014 | Volume
: 6
| Issue : 2 | Page : 65-68 |
|
Anti-helminthic drugs in recurrent apthous stomatitis: A short review
Shilpa Sharma1, Fareedi Mukram Ali2, Kedar Saraf1, Anupama Mudhol2
1 Department of Oral Medicine and Radiology, SMBT Dental College, Sangamner, Ahmednagar, Maharashtra, India 2 Department of Oral and Maxillofacial Surgery, SMBT Dental College, Sangamner, Ahmednagar, Maharashtra, India
Correspondence Address:
Fareedi Mukram Ali Department of Oral and Maxillofacial Surgery, SMBT Dental College, Sangamner, Ahmednagar, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0975-7406.129169
|
|
Recurrent aphthous stomatitis (RAS) is a common mucosal condition producing painful ulcerations in the oral cavity and considerable clinical morbidity. The etiology remains obscure, though local trauma, psychologic stress, hematinic deficiencies and immune dysregulation have been implicated. Though the primary goals of therapy are symptomatic relief of pain, the clinicians are aiming toward reducing the frequency, duration, number of ulcerations and increasing ulcer free periods with systemic drug therapy if topical medications appear ineffective. Levamisole, an antihelminthic drug has been tried with promising results in patients with severe RAS providing long-term benefits. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|